Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative iloprost blood-flow measurement in diabetic and non-diabetic patients with arteriosclerosis
2011-004567-80Phase 2Completed
- Sponsor
- Georg Hagmüller Institute for Vascular Research
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of iloprost in peripheral artery occlusion (PAD) and arteriosclerosis (2 arms), sponsored by Georg Hagmüller Institute for Vascular Research. Started Apr 2012; status: completed.
02
Drugs
iloprost
03
Conditions
peripheral artery occlusion (PAD)arteriosclerosis
Beyond the preview
Go deeper on 2011-004567-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004567-80.